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Yoshihiro Fukuoka (MD)a,*, Norihito Nuruki (MD)a, Shun Amiya (MD, PhD)a,
Katsunori Tofuku (MD)a, Shinichiro Aosaki (MD, PhD)b, Hirohito Tsubouchi (MD, PhD)a
aDepartment of Digestive and Life-style Related Diseases, Human Environmental Sciences, Health Research Studies, Kagoshima University Graduate School of
Medical and Dental Sciences, Kagoshima, Japan
b Saiseikai Sendai Hospital, Kagoshima, JapanThe publisher regrets that there is an error in the above paper. On page 213, Table 2 should have been as below.
The publisher would like to apologise for any inconvenience caused.Table 2
Baseline risks for increased baPWV during a 6-month ﬁsh-based diet.
DbaPWV: >0 DbaPWV: 20 p-valuea
N 92 99
DbaPWV (cm/s) 121115 128115 <0.0001*
Age (years) 68.110.6 72.39.8 0.0050*
Male (%) 59 (64.1%) 51 (50.5%) 0.0779
Body mass index (kg/m2) 24.33.9 23.83.0 0.3128
Hypertension (%) 83 (90.2%) 90 (90.9%) 0.8701
Systolic blood pressure (mmHg) 133.213.9 134.416.4 0.5889
Pulse rate (bpm) 63.710.2 64.410.8 0.6331
Diabetes (%) 18 (19.6%) 16 (16.2%) 0.5389
HbA1c (%) 5.60.6 5.40.4 0.0477*
Dyslipidemia (%) 39 (42.4%) 35 (35.4%) 0.3185
LDL-C (mg/dL) 102.827.9 110.230.3 0.0818
HDL-C (mg/dL) 58.717.4 58.417.4 0.9049
LDL-C/HDL-C ratio 1.880.73 2.000.64 0.2397
Triglyceride (mg/dL) 116.454.6 105.142.2 0.1111
EPA (mg/mL) 74.435.3 76.841.1 0.6717
DHA (mg/mL) 165.350.0 170.057.2 0.5445
AA (mg/mL) 181.549.7 180.240.6 0.8534
EPA/AA ratio 0.420.18 0.430.20 0.7121
Estimated GFR (mL/min/1.73m2) 64.813.1 63.515.1 0.5083
baPWV (cm/s) 1732309 1909395 0.0007*
Maximum IMT (mm) 2.061.23 1.950.80 0.4749
Left ventricular hypertrophy (%) 49 (53.3%) 56 (56.6%) 0.6465
Low-risk with no prior history of CAD (%) 44 (47.8%) 62 (62.6%) 0.0397*
High-risk with no prior history of CAD (%) 10 (10.9%) 13 (13.1%) 0.6313
CAD patients (%) 38 (41.3%) 24 (24.2%) 0.0119*
Medication
Statin (%) 49 (53.3%) 40 (40.4%) 0.0751
RAS inhibitors (%) 62 (67.4%) 63 (63.6%) 0.5856
Data are number of patients (%) or mean SD. Hb, hemoglobin; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein
cholesterol; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; AA, arachidonic acid; GFR, glomerular ﬁltration rate; baPWV, brachial-ankle
pulse wave velocity; IMT, intima-media thickness; CAD, coronary artery disease; RAS, renin–angiotensin system.
a Unpaired Student’s t-test or x2-test.
* p<0.05.
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